MiR-590-5p Affects Chondrocyte Proliferation, Apoptosis, and Inflammation by Targeting FGF18 in Osteoarthritis
Overview
Affiliations
Objective: To investigate the potential miRNA targeting FGF18, and its role in regulating the proliferation, apoptosis and inflammation in human primary chondrocytes.
Methods: The normal human chondrocytes were induced by IL-1β to mimic OA . qPCR and Western blotting were performed to evaluate the expression of FGF18. Target Scan analysis was performed to predict the miRNA targeting FGF18. Then, the expression of miR-590-5p was quantified by qPCR in IL-1β-induced chondrocytes. After transfection of miR-590-5p mimics or inhibitors, CCK-8 assay was conducted to determine the cell viability and apoptosis-related proteins, and cartilage degeneration related biomarkers were assayed by qPCR and Western blotting. The levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-8 were determined by ELISA. The targeting relationship between miR-590-5p and FGF18 was assayed by luciferase reporter assay in IL-1β-induced chondrocytes.
Results: Target Scan analysis predicted that FGF18 is directly targeted by miR-590-5p. miR-590-5p was up-regulated, whereas FGF18 expression was inhibited in IL-1β-induced chondrocytes. miR-590-5p mimics reduced the expression of FGF18 protein, inhibited the cell viability of chondrocytes, and promoted secretion of inflammatory factors in chondrocytes, while miR-590-5p inhibitors increased FGF18 levels in IL-1β-treated chondrocytes. Furthermore, expression of inflammatory factors in chondrocytes was reduced by miR-590-5p inhibitors. The luciferase reporter assay showed that miR-590-5p could target FGF18.
Conclusions: miR-590-5p promotes OA progression by targeting FGF18, which serves as a potential therapeutic target for OA.
Serum and Plasma miRNA Expression Levels in Sudden Sensorineural Hearing Loss.
Nunez D, Abgoon R, Wijesinghe P, Garnis C Int J Mol Sci. 2025; 26(3).
PMID: 39941013 PMC: 11818497. DOI: 10.3390/ijms26031245.
Wu Y, Chen W, Jian J, Liu W, Wang H, Gao D Mol Divers. 2024; 29(1):319-336.
PMID: 38622351 DOI: 10.1007/s11030-024-10854-4.
Botor M, Augusciak-Duma A, Lesiak M, Sieron L, Dziedzic-Kowalska A, Witecka J Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895885 PMC: 10609877. DOI: 10.3390/ph16101414.
Tong G, Chen Y, Chen X, Fan J, Zhu K, Hu Z Nat Commun. 2023; 14(1):6107.
PMID: 37777507 PMC: 10542385. DOI: 10.1038/s41467-023-41800-x.
Huang F, Su Z, Yang J, Zhao X, Xu Y J Orthop Surg Res. 2023; 18(1):670.
PMID: 37691099 PMC: 10494329. DOI: 10.1186/s13018-023-04147-z.